Oxidative Storm Induced by Tryptophan Metabolites: Missing Link Between Atherosclerosis and Chronic Kidney Disease

Overview

Journal Oxid Med Cell Longev

Publisher Wiley

Specialties Cell Biology
Endocrinology

Date 2021 Jan 18

PMID 33456671

Citations 13

Authors

Iwona Kwiatkowska

Justyna M Hermanowicz

Michal Mysliwiec

Dariusz Pawlak

Affiliations

Soon will be listed here.

Abstract

Chronic kidney disease (CKD) occurrence is rising all over the world. Its presence is associated with an increased risk of premature death from cardiovascular disease (CVD). Several explanations of this link have been put forward. It is known that in renal failure, an array of metabolites cannot be excreted, and they accumulate in the organism. Among them, some are metabolites of tryptophan (TRP), such as indoxyl sulfate and kynurenine. Scientists have become interested in them in the context of inducing vascular damage in the course of chronic kidney impairment. Experimental evidence suggests the involvement of TRP metabolites in the progression of chronic kidney disease and atherosclerosis separately and point to oxidative stress generation as one of the main mechanisms that is responsible for worsening those states. Since it is known that blood levels of those metabolites increase significantly in renal failure and that they generate reactive oxygen species (ROS), which lead to endothelial injury, it is reasonable to suspect that products of TRP metabolism are the missing link in frequently occurring atherosclerosis in CKD patients. This review focuses on reports that shed a light on TRP metabolites as contributing factors to vascular damage in the progression of impaired kidney function.

Citing Articles

Kynurenines and aerobic exercise capacity in chronic kidney disease: A cross-sectional and longitudinal study.

Wallin H, Jansson E, Erhardt S, Wallquist C, Hylander B, Jacobson S PLoS One. 2025; 20(1):e0317201.

PMID: 39813270 PMC: 11734918. DOI: 10.1371/journal.pone.0317201.

Association between atherosclerosis and the development of multi-organ pathologies.

Dabravolski S, Churov A, Elizova N, Ravani A, Karimova A, Sukhorukov V SAGE Open Med. 2024; 12:20503121241310013.

PMID: 39734765 PMC: 11672402. DOI: 10.1177/20503121241310013.

Mitochondrial metabolic reprogramming in diabetic kidney disease.

Fan X, Yang M, Lang Y, Lu S, Kong Z, Gao Y Cell Death Dis. 2024; 15(6):442.

PMID: 38910210 PMC: 11194272. DOI: 10.1038/s41419-024-06833-0.

Study of the association between serum levels of kynurenine and cardiovascular outcomes and overall mortality in chronic kidney disease.

El Chamieh C, Larabi I, Alencar De Pinho N, Lambert O, Combe C, Fouque D Clin Kidney J. 2024; 17(1):sfad248.

PMID: 38186868 PMC: 10768787. DOI: 10.1093/ckj/sfad248.

Mixed storm in SARS-CoV-2 infection: A narrative review and new term in the Covid-19 era.

Alomair B, Al-Kuraishy H, Al-Gareeb A, Al-Buhadily A, Alexiou A, Papadakis M Immun Inflamm Dis. 2023; 11(4):e838.

PMID: 37102645 PMC: 10132185. DOI: 10.1002/iid3.838.

References

Song H, Park H, Kim Y, Kim K, Lee H, Cho D . L-kynurenine-induced apoptosis in human NK cells is mediated by reactive oxygen species. Int Immunopharmacol. 2011; 11(8):932-8. DOI: 10.1016/j.intimp.2011.02.005. View

Ng C, Fong L, Sulaiman M, Mohd Moklas M, Yong Y, Hakim M . Interferon-Gamma Increases Endothelial Permeability by Causing Activation of p38 MAP Kinase and Actin Cytoskeleton Alteration. J Interferon Cytokine Res. 2015; 35(7):513-22. DOI: 10.1089/jir.2014.0188. View

Kaminski T, Pawlak K, Karbowska M, Mysliwiec M, Pawlak D . Indoxyl sulfate - the uremic toxin linking hemostatic system disturbances with the prevalence of cardiovascular disease in patients with chronic kidney disease. BMC Nephrol. 2017; 18(1):35. PMC: 5267373. DOI: 10.1186/s12882-017-0457-1. View

Shen W, Liang C, Huang T, Liu C, Wang S, Young G . Indoxyl sulfate enhances IL-1β-induced E-selectin expression in endothelial cells in acute kidney injury by the ROS/MAPKs/NFκB/AP-1 pathway. Arch Toxicol. 2015; 90(11):2779-2792. DOI: 10.1007/s00204-015-1652-0. View

Yeh Y, Huang M, Liang S, Hwang S, Tsai J, Liu T . Indoxyl sulfate, not p-cresyl sulfate, is associated with cognitive impairment in early-stage chronic kidney disease. Neurotoxicology. 2016; 53:148-152. DOI: 10.1016/j.neuro.2016.01.006. View

Tucker P, Dalbo V, Han T, Kingsley M . Clinical and research markers of oxidative stress in chronic kidney disease. Biomarkers. 2013; 18(2):103-15. DOI: 10.3109/1354750X.2012.749302. View

Six I, Gross P, Remond M, Chillon J, Poirot S, Drueke T . Deleterious vascular effects of indoxyl sulfate and reversal by oral adsorbent AST-120. Atherosclerosis. 2015; 243(1):248-56. DOI: 10.1016/j.atherosclerosis.2015.09.019. View

Topczewska-Bruns J, Pawlak D, Chabielska E, Tankiewicz A, Buczko W . Increased levels of 3-hydroxykynurenine in different brain regions of rats with chronic renal insufficiency. Brain Res Bull. 2002; 58(4):423-8. DOI: 10.1016/s0361-9230(02)00813-4. View

Pawlak K, Brzosko S, Mysliwiec M, Pawlak D . Kynurenine, quinolinic acid--the new factors linked to carotid atherosclerosis in patients with end-stage renal disease. Atherosclerosis. 2008; 204(2):561-6. DOI: 10.1016/j.atherosclerosis.2008.10.002. View

10.

Luczak A, Madej M, Kasprzyk A, Doroszko A . Role of the eNOS Uncoupling and the Nitric Oxide Metabolic Pathway in the Pathogenesis of Autoimmune Rheumatic Diseases. Oxid Med Cell Longev. 2020; 2020:1417981. PMC: 7174952. DOI: 10.1155/2020/1417981. View

11.

Kuo K, Zhao J, Huang P, Guo B, Tarng D, Lee T . Indoxyl sulfate impairs valsartan-induced neovascularization. Redox Biol. 2020; 30:101433. PMC: 6974788. DOI: 10.1016/j.redox.2020.101433. View

12.

Agus A, Planchais J, Sokol H . Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease. Cell Host Microbe. 2018; 23(6):716-724. DOI: 10.1016/j.chom.2018.05.003. View

13.

Nguyen D, Theodoropoulos G, Li Y, Wu C, Sha W, Feun L . Targeting the Kynurenine Pathway for the Treatment of Cisplatin-Resistant Lung Cancer. Mol Cancer Res. 2019; 18(1):105-117. PMC: 7262740. DOI: 10.1158/1541-7786.MCR-19-0239. View

14.

Wang L, Gao Z, Wang L, Gao Y . Upregulation of nuclear factor-κB activity mediates CYP24 expression and reactive oxygen species production in indoxyl sulfate-induced chronic kidney disease. Nephrology (Carlton). 2015; 21(9):774-81. DOI: 10.1111/nep.12673. View

15.

Savitz J . The kynurenine pathway: a finger in every pie. Mol Psychiatry. 2019; 25(1):131-147. PMC: 6790159. DOI: 10.1038/s41380-019-0414-4. View

16.

Thomas S, Witting P, Stocker R . 3-Hydroxyanthranilic acid is an efficient, cell-derived co-antioxidant for alpha-tocopherol, inhibiting human low density lipoprotein and plasma lipid peroxidation. J Biol Chem. 1996; 271(51):32714-21. DOI: 10.1074/jbc.271.51.32714. View

17.

Nguyen N, Nakahama T, Le D, Son L, Chu H, Kishimoto T . Aryl hydrocarbon receptor and kynurenine: recent advances in autoimmune disease research. Front Immunol. 2014; 5:551. PMC: 4212680. DOI: 10.3389/fimmu.2014.00551. View

18.

Liu T, Chen X, Sun J, Jiang X, Wu Y, Yang S . Palmitic Acid-Induced Podocyte Apoptosis via the Reactive Oxygen Species-Dependent Mitochondrial Pathway. Kidney Blood Press Res. 2018; 43(1):206-219. DOI: 10.1159/000487673. View

19.

Erhardt S, Schwieler L, Imbeault S, Engberg G . The kynurenine pathway in schizophrenia and bipolar disorder. Neuropharmacology. 2016; 112(Pt B):297-306. DOI: 10.1016/j.neuropharm.2016.05.020. View

20.

Gamboa J, Billings 4th F, Bojanowski M, Gilliam L, Yu C, Roshanravan B . Mitochondrial dysfunction and oxidative stress in patients with chronic kidney disease. Physiol Rep. 2016; 4(9). PMC: 4873632. DOI: 10.14814/phy2.12780. View